Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Inovio Pharmaceuticals
INO
$68.5M
| $2M | ﹤0.01% |
96,373
+95,454
| +10,387% | +$2.44M |
|
1702
Radian Group
RDN
$5.27B
| $1.99M | ﹤0.01% |
103,359
-38,354
| -27% | -$817K |
|
|
TLGY
1703
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
| $1.99M | ﹤0.01% |
197,210
+102,210
| +108% | +$1.03M |
|
1704
Veeco
VECO
$3.28B
| $1.98M | ﹤0.01% |
108,259
+7,620
| +8% | +$156K |
|
|
SASR
1705
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.98M | ﹤0.01% |
56,262
-1,266
| -2% | -$49.9K |
|
1706
Royal Gold
RGLD
$17.5B
| $1.98M | ﹤0.01% |
21,122
-25,878
| -55% | -$2.56M |
|
|
EPWR
1707
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
| $1.98M | ﹤0.01% |
200,097
+97
| +0% | +$957 |
|
1708
iShares MSCI Switzerland ETF
EWL
$2.21B
| $1.97M | ﹤0.01% |
52,663
-40,136
| -43% | -$1.66M |
|
|
CCVI
1709
DELISTED
Churchill Capital Corp VI
CCVI
| $1.97M | ﹤0.01% |
200,641
+1,466
| +0.7% | +$14.4K |
|
1710
Cullen/Frost Bankers
CFR
$10.5B
| $1.97M | ﹤0.01% |
14,890
-9,983
| -40% | -$1.31M |
|
|
CUTR
1711
DELISTED
Cutera, Inc.
CUTR
| $1.97M | ﹤0.01% |
43,203
-8,686
| -17% | -$396K |
|
|
FM
1712
DELISTED
iShares Frontier and Select EM ETF
FM
| $1.97M | ﹤0.01% |
+80,900
| New | +$2.18M |
|
1713
Coherus Oncology
CHRS
$228M
| $1.97M | ﹤0.01% |
204,804
+162,448
| +384% | +$1.64M |
|
|
MBSC
1714
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
| $1.97M | ﹤0.01% |
195,218
| – | – |
|
1715
iShares MSCI Germany ETF
EWG
$1.62B
| $1.97M | ﹤0.01% |
99,571
+92,760
| +1,362% | +$2.07M |
|
1716
Forward Air
FWRD
$484M
| $1.96M | ﹤0.01% |
21,733
+11,828
| +119% | +$1.16M |
|
1717
iShares TIPS Bond ETF
TIP
$14.5B
| $1.96M | ﹤0.01% |
18,672
-1,330,828
| -99% | -$151M |
|
1718
Stepan Co
SCL
$1.45B
| $1.96M | ﹤0.01% |
20,877
-4,367
| -17% | -$454K |
|
1719
Anavex Life Sciences
AVXL
$292M
| $1.95M | ﹤0.01% |
189,290
+179,290
| +1,793% | +$1.89M |
|
1720
GameStop
GME
$8.62B
| $1.95M | ﹤0.01% |
77,739
-77,205
| -50% | -$2.52M |
|
|
WEL
1721
DELISTED
Integrated Wellness Acquisition Corp
WEL
| $1.95M | ﹤0.01% |
192,909
| – | – |
|
1722
Enovis
ENOV
$1.78B
| $1.95M | ﹤0.01% |
42,278
-3,916
| -8% | -$212K |
|
|
SFBS
1723
ServisFirst Bancshares
SFBS
$4.97B
| $1.94M | ﹤0.01% |
24,295
-7,838
| -24% | -$661K |
|
1724
Patterson-UTI
PTEN
$3.83B
| $1.94M | ﹤0.01% |
166,034
+64,456
| +63% | +$921K |
|
1725
Jackson Financial
JXN
$9.32B
| $1.93M | ﹤0.01% |
69,358
+46,484
| +203% | +$1.37M |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $66.4B in Q3 2022, closing 533 positions and reducing 1,954 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $99.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Pacer iPath Gold ETNs worth $27.1M.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.